Yilmaz, N. S. Et Al. 2022. A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study. Journal of Neural Transmission , vol.129, no.12 , 1513-1526.

Yilmaz, N. S., Sen, B., Karadag, R. F., Aslan, S., Ekmekci Ertek, I., Bozkurt, A., ... Cicek, S.(2022). A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study. Journal of Neural Transmission , vol.129, no.12, 1513-1526.

Yilmaz, Niyazi Et Al. "A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study," Journal of Neural Transmission , vol.129, no.12, 1513-1526, 2022

Yilmaz, Niyazi S. Et Al. "A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study." Journal of Neural Transmission , vol.129, no.12, pp.1513-1526, 2022

Yilmaz, N. S. Et Al. (2022) . "A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study." Journal of Neural Transmission , vol.129, no.12, pp.1513-1526.

@article{article, author={Niyazi Samet Yilmaz Et Al. }, title={A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study}, journal={Journal of Neural Transmission}, year=2022, pages={1513-1526} }